MedPath

Validating the Dutch and Flemisch PCOSQ and PCOSQOL in women with PCOS

Conditions
Polycystic ovary syndrome (PCOS)
Registration Number
NL-OMON20309
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
410
Inclusion Criteria

Female gender
- 18 years old and above
- Dutch or Flemish as a first language
- Diagnosed with PCOS according to the Rotterdam 2003 consensus criteria [2] and International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018 [1].

Exclusion Criteria

- Women with inadequate knowledge of the Dutch or Flemish language.
- Pregnant at moment of occasion 1 or 2.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of this study is the development of a Dutch and Flemisch version of the PCOSQ and PCOSQOL measured with the PCOSQ and PCOSQOL at T0 (start)
Secondary Outcome Measures
NameTimeMethod
The secondary outcomes of this study are the test-retest reliability and the domain structure of the PCOSQ and PCOSQOL for the Dutch and Flemish population by measuring the PCOSQ and PCOSQOL. This secondary outcome will be measured with the PCOSQ and PCOSQOL at T0 (start) and two weeks later (T1)
© Copyright 2025. All Rights Reserved by MedPath